Jun 14, 2018
WuXi STA First CDMO to Support the Approval of an Innovative Drug in China Through the "MAH" Pilot
Jun 11, 2018
WuXi AppTec Leads Strategic Investment in Insilico Medicine to Accelerate Drug Discovery Using Next-Generation Artificial Intelligence
May 29, 2018
Medtec China launches regulatory zone to speed up the internationalization of medical device industry in China; WuXi AppTec confirmed to exhibit
May 07, 2018
WuXi AppTec Announces Listing of Initial Public Offering of Common Stock on Shanghai Stock Exchange
Apr 26, 2018
WuXi STA Announces to Build a New R&D Center in Shanghai
Apr 18, 2018
WuXi AppTec Expands Site in the United States for Drug Development Testing Services
Mar 21, 2018
Nohla Therapeutics Selects Advanced Therapies Business Unit of WuXi AppTec to Manufacture Universal Donor Cell Therapies
Feb 22, 2018
WuXi STA and Regulus Announce microRNA Development and Manufacturing Collaboration
Feb 06, 2018
WuXi AppTec Launches Advanced Library Compound Initiative on LabNetwork.com
Jan 09, 2018
WuXi AppTec Group and Mayo Clinic Form Joint Venture to Deliver Clinical Diagnostic Services
Nov 17, 2017
WuXi AppTec Selected by IQVIA Stem Cell Center to Serve as GMP Manufacturer of Advanced Therapies
Nov 17, 2017
WuXi AppTec elected by IQVIA Stem Cell Center to Serve as GMP Manufacturer of Advanced Therapies
Oct 17, 2017
WuXi AppTec Acquires ResearchPoint Global to Better Enable Clinical Development Worldwide
Oct 08, 2017
WuXi AppTec Receives 2017 Global Integrated Drug R&D Services Competitive Strategy Innovation & Leadership Award from Frost & Sullivan
Jul 30, 2017
WuXi's Pharmaceutical Development Services Division Merges with STA